IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
Bioengineering & Translational Medicine
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Wiley
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239364 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-239364 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2393642024-04-25T01:21:40Z IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh TL Le, Nguyen Chan, Conrad EZ Desai, Rishi Ding, Xianting Hanson, Brendon J Chow, Edward Kai-Hua Ho, Dean LIFE SCIENCES INSTITUTE BIOMEDICAL ENGINEERING CANCER SCIENCE INSTITUTE OF SINGAPORE SURGERY DUKE-NUS MEDICAL SCHOOL PHARMACOLOGY Bioengineering & Translational Medicine 6 1 2023-05-12T08:39:20Z 2023-05-12T08:39:20Z 2021-01 2023-05-12T06:20:17Z Article Blasiak, Agata, Lim, Jhin Jieh, Seah, Shirley Gek Kheng, Kee, Theodore, Remus, Alexandria, Chye, De Hoe, Wong, Pui San, Hooi, Lissa, Truong, Anh TL, Le, Nguyen, Chan, Conrad EZ, Desai, Rishi, Ding, Xianting, Hanson, Brendon J, Chow, Edward Kai-Hua, Ho, Dean (2021-01). IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. Bioengineering & Translational Medicine 6 (1). ScholarBank@NUS Repository. 2380-6761 https://scholarbank.nus.edu.sg/handle/10635/239364 Wiley Elements |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
description |
Bioengineering & Translational Medicine |
author2 |
LIFE SCIENCES INSTITUTE |
author_facet |
LIFE SCIENCES INSTITUTE Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh TL Le, Nguyen Chan, Conrad EZ Desai, Rishi Ding, Xianting Hanson, Brendon J Chow, Edward Kai-Hua Ho, Dean |
format |
Article |
author |
Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh TL Le, Nguyen Chan, Conrad EZ Desai, Rishi Ding, Xianting Hanson, Brendon J Chow, Edward Kai-Hua Ho, Dean |
spellingShingle |
Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh TL Le, Nguyen Chan, Conrad EZ Desai, Rishi Ding, Xianting Hanson, Brendon J Chow, Edward Kai-Hua Ho, Dean IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development |
author_sort |
Blasiak, Agata |
title |
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development |
title_short |
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development |
title_full |
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development |
title_fullStr |
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development |
title_full_unstemmed |
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development |
title_sort |
identif.ai: rapidly optimizing combination therapy design against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) with digital drug development |
publisher |
Wiley |
publishDate |
2023 |
url |
https://scholarbank.nus.edu.sg/handle/10635/239364 |
_version_ |
1800915838401773568 |